Teva Inks $4.35bn Nationwide US Opioids Settlement Agreement
US-Wide Documentation To Be Finalized ‘Within The Coming Weeks’
Executive Summary
Teva is to put more than $3bn in cash on the table over the next 13 years to resolve longstanding opioid-related claims against the company in the US.
You may also be interested in...
Five Big Legal Stories From 2022
Generics Bulletin looks back at a selection of the most significant legal stories from 2022, including a major victory in the UK on the Eliquis blood thinner giant and continued action on generic label carve outs, which has the potential to reverberate through the US industry.
Long-Awaited Nationwide Opioid Settlement To Move Forward For Teva
Teva has all but two US states on board for its long-hoped-for nationwide settlement to resolve opioid-related claims against the firm.
Teva Agrees $931,000 For Arkansas To Dismiss Price-Fixing Claims
Teva will pay $931, 000 to dismiss price-fixing claims filed in a 2020 multistate lawsuit but its legal troubles are far from over.